A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2001
11/29/2001	CA2410530A1 Method of promoting smoking cessation
11/29/2001	CA2410401A1 A novel treatment for cough
11/29/2001	CA2410395A1 Agents and methods for increasing brain chaperonin levels
11/29/2001	CA2410338A1 Tyrosine phosphatase inhibitors
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2410293A1 Three-layer parenteral preparations
11/29/2001	CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2410094A1 Compositions and methods for modulating tumor specific expression
11/29/2001	CA2410014A1 Medicaments for treating colics
11/29/2001	CA2410004A1 Aerosol container for formulations of salmeterol xinafoate
11/29/2001	CA2409998A1 Benzodiazepine derivatives as app modulators
11/29/2001	CA2409980A1 Conjugates of aminodrugs comprising an oxime bond
11/29/2001	CA2409950A1 Pharmaceutical compositions comprising desglymidodrine as an active drug substance
11/29/2001	CA2409929A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
11/29/2001	CA2409873A1 Hcv variants
11/29/2001	CA2409856A1 Novel amorphous form of sertraline hydrochloride
11/29/2001	CA2409830A1 Sulfonamide derivatives
11/29/2001	CA2409829A1 Sulfonamide derivatives
11/29/2001	CA2409772A1 Antiviral therapy
11/29/2001	CA2409768A1 Cyclic amino acid derivatives useful as pharmaceutical agents
11/29/2001	CA2409688A1 Method for improving the cell protection
11/29/2001	CA2409644A1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	CA2409259A1 Novel antibiotic compounds
11/29/2001	CA2408791A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/29/2001	CA2408783A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	CA2408781A1 Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone
11/29/2001	CA2408777A1 Dosage of transdermal delivery systems
11/29/2001	CA2408743A1 Method of detecting inflammatory lung disorders
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408562A1 Dehydroascorbic acid formulations and uses thereof
11/29/2001	CA2408145A1 Aniline disulfide derivatives for treating allergic diseases
11/29/2001	CA2408036A1 Combination of growth hormone secretagogues and antidepressants
11/29/2001	CA2408033A1 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
11/29/2001	CA2407964A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	CA2407784A1 Treatment of acute coronary syndrome with glp-1
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2407767A1 Compositions containing a benzamide disulfide derivative for treating allergic diseases
11/29/2001	CA2407764A1 O/w emulsion
11/29/2001	CA2407570A1 Compositions and methods for delivery of a molecule into a cell
11/29/2001	CA2407028A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2405459A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
11/29/2001	CA2403574A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158297A1 Method for screening compound having affinity for vitamin d receptor
11/28/2001	EP1158004A2 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
11/28/2001	EP1158000A1 Crystal structure data of cystalysin and use thereof for the design and preparation of inhibitor molecules
11/28/2001	EP1157998A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors
11/28/2001	EP1157996A1 New solid forms of mesoprogestin 11beta-(4E-(hydroxyiminomethyl)-phenyl)-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on
11/28/2001	EP1157992A1 Dihydro-2,3-Benzodiazepine derivatives
11/28/2001	EP1157987A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
11/28/2001	EP1157749A2 Metered dose inhaler for albuterol
11/28/2001	EP1157705A2 Use of a phosphodiesterase inhibitor in the manufacture of a medicament for blood pressure stabilization during hemodialysis
11/28/2001	EP1157704A1 Remedies or preventives for ischemic reflow failure
11/28/2001	EP1157702A1 Compositions comprising DNA Damaging Agents and p53
11/28/2001	EP1157700A1 Anti-hiv agent
11/28/2001	EP1157698A2 Treatment of inflammatory diseases with oxypurine nucleosides
11/28/2001	EP1157697A1 Remedies for hyperammonemia
11/28/2001	EP1157696A2 Treatment of rumen acidosis with alpha-amylase inhibitors
11/28/2001	EP1157695A1 Method of treating obesity using a neurotensin receptor ligand
11/28/2001	EP1157694A1 Remedial agent for erectile dysfunction
11/28/2001	EP1157693A1 Use of epigallocatechin 3-o-(3-o-methyl) gallate and/or epigallocatechin 3-o-(4-o-methyl) gallate for the treatment of allergy and/or inflammation
11/28/2001	EP1157692A1 Composition of fatty acids containing at least 80% by weight of EPA and DHA or their derivatives and its pharmaceutical use
11/28/2001	EP1157690A1 Sustained release pharmaceutical composition
11/28/2001	EP1157689A1 Stable pharmaceutical solution formulations for pressurised metered dose inhalers
11/28/2001	EP1157682A1 Blister package for topiramate tablets
11/28/2001	EP1157275A1 Novel transduction molecules and methods for using same
11/28/2001	EP1157104A2 Pyk2 binding proteins
11/28/2001	EP1157031A1 Oligomers substituted by phosphonic acid ester, phosphonic acid or carbaborane functions and the corresponding pna monomers
11/28/2001	EP1157026A1 Polycyclo heterocyclic derivatives as antiinflammatory agents
11/28/2001	EP1157024A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/28/2001	EP1157023A1 C-21 modified epothilones
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157019A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
11/28/2001	EP1157011A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
11/28/2001	EP1157009A1 Dopamine d1 receptor agonist compounds
11/28/2001	EP1157006A2 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
11/28/2001	EP1157005A1 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
11/28/2001	EP1157003A1 Acylated aminoacetonitriles as cysteine protease inhibitors
11/28/2001	EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP1157000A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/28/2001	EP1156999A1 Method for the preparation of a chiral-beta-amino ester
11/28/2001	EP1156856A2 Uses of fluorinated triazoles for treaing pain and affective or attention disorders
11/28/2001	EP1156855A1 Composition comprising a tramadol material and a selective cox-2 inhibitor drug
11/28/2001	EP1156854A2 Use of ceramides for the treatment of cystic fibrosis
11/28/2001	EP1156853A2 Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or h 2? receptor antagonists
11/28/2001	EP1156852A2 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h 2? receptor antagonists
11/28/2001	EP1156829A1 Stable formulation containing fumagillin
11/28/2001	EP1156828A1 Combination therapy for lymphoproliferative diseases
11/28/2001	EP1156827A2 Treatment of neoplastic diseases by radiation
11/28/2001	EP1156822A1 Treatment of infertility
11/28/2001	EP1156821A1 Treatment of infertility
11/28/2001	EP1156815A2 Process for extracting polyphenolic antioxidants from purine-containing plants

1 ... 5957 5958 5959 5960 5961 5962 5963 5964 5965 5966 5967 5968 5969 5970 5971 5972 5973 5974 5975 5976 5977 ... 7860